CNS Drugs, Sedatives, Opioids, Anesthesia & Euthanasia Review

CNS Drugs Overview and General Depressants

• Definition and Scope of CNS Depressants:

  • Central Nervous System (CNS) depressants are agents used to achieve various states of neurological suppression.

  • Primary clinical effects include sedation, tranquilization, anesthesia, and skeletal muscle relaxation.

• General Clinical Monitoring Requirements:

  • Due to the suppressive nature of these drugs, medical staff must continuously monitor the following physiological parameters:

    • Respiratory rate (RR).

    • Heart rate (HR).

    • Blood pressure (BP).

    • Body temperature (to detect hypothermia).

    • Oxygenation (SpO2 levels).

• Pathological Signs of Overdose:

  • The following clinical indicators suggest a dangerous level of CNS depression or overdose:

    • Respiratory depression.

    • Bradycardia (abnormally slow heart rate).

    • Hypotension (abnormally low blood pressure).

    • Unconsciousness.

Phenothiazines (Acepromazine)

• Pharmacodynamic Properties:

  • Acepromazine functions strictly as a tranquilizer.

  • Crucial Note: It provides tranquilization ONLY and offers absolutely $0$ analgesia (pain relief).

• Clinical Side Effects:

  • Hypotension.

  • Hypothermia.

  • Prolapsed third eyelid (a common ocular sign in veterinary patients).

• Precautions and Contraindications:

  • Should be used with extreme caution in patients suffering from shock or dehydration due to hypotensive effects.

  • Special consideration is required when administering to specific dog breeds, notably Boxers and giant breeds.

Benzodiazepines

• Primary Agents: Diazepam and Midazolam.

• Clinical Applications:

  • Utilized for acute seizure control.

  • Effective for muscle relaxation and general sedation.

• Pharmacological Benefits:

  • Characterized by minimal cardiovascular depression compared to other sedatives.

  • Midazolam is specifically noted as being water soluble.

• Side Effects:

  • Ataxia (lack of muscle coordination).

  • Potential for paradoxical excitement.

Alpha2 Agonists and Reversal Agents

• Primary Agents: Dexmedetomidine and Xylazine.

• Clinical Profile:

  • Provides a triad of effects: sedation, analgesia, and muscle relaxation.

• Physiological Side Effects:

  • Bradycardia.

  • Vasoconstriction.

  • Emesis (vomiting).

• Specific Species Sensitivity:

  • Ruminants are exceptionally sensitive to the effects of Xylazine.

• Reversal Pharmacotherapy:

  • Atipamezole is the specific reversal agent for Alpha2 agonists.

Opioids and Antagonists

• Pharmacological Role: Primary agents for providing analgesia.

• Common Opioid Agents:

  • Morphine: A strong opioid; causes vomiting and respiratory depression.

  • Hydromorphone: More potent than morphine; often causes panting in dogs.

  • Fentanyl: Used for severe pain; high risk of respiratory depression; commonly administered via transdermal patches.

  • Butorphanol: Used for mild pain and as a cough suppressant (antitussive); causes sedation.

  • Buprenorphine: (Categorized as an opioid utilized for analgesia).

• Systemic Side Effects:

  • Respiratory depression.

  • Gastrointestinal (GI) slowing.

  • Urinary retention.

• Species-Specific Behavioral Reactions:

  • Dogs: Frequently exhibit panting.

  • Cats: May experience excitation or dysphoria.

• Opioid Antagonist: Naloxone:

  • Function: Reverses respiratory depression, sedation, and analgesia.

  • Onset of Action: Works rapidly when administered Intravenously (IV).

  • Clinical Usage: Repeated doses may be necessary as the duration of the opioid may exceed the duration of the antagonist. Reversal results in the sudden return of pain.

Neuroleptanalgesia

• Definition: A pharmacological state produced by the combination of an opioid and a sedative or tranquilizer.

• Advantages:

  • Significantly improves chemical restraint.

  • Facilitates a smoother induction into anesthesia.

Anticonvulsant Therapy and Seizure Drugs

• Long-Term Management (Phenobarbital):

  • Used for chronic seizure control.

  • Requires regular monitoring of blood levels and liver values due to potential liver damage.

• Emergency Management (Diazepam):

  • The preferred agent for treating status epilepticus or active, emergency seizures.

• Additional Agents:

  • Potassium bromide: Used for seizures, though it must be used very cautiously in feline patients.

• Critical Safety Protocol: Never cease the administration of anticonvulsants suddenly, as this may trigger refractory seizures.

General Anesthesia and Induction Agents

• Propofol:

  • An Intravenous (IV) induction anesthetic agent.

  • Properties: Rapid induction and rapid recovery.

  • Negative Effects: Can cause apnea (temporary cessation of breathing) and hypotension.

  • Handling: Requires strict aseptic handling and technique.

• Guaifenesin:

  • Primary Use: Skeletal muscle relaxation in horses.

  • Analgesia: Provides NO analgesia.

  • Standard Protocol: Often combined with Ketamine and Xylazine.

• Inhalant Anesthetics:

  • Isoflurane: Common clinical choice; affordable.

  • Sevoflurane: Noted for faster induction and faster recovery times than Isoflurane.

  • Nitrous oxide: A weak anesthetic agent; exclusively used in conjunction with other anesthetic agents.

Specialized Support and Calming Agents

• Doxapram:

  • Classification: Respiratory stimulant.

  • Indications: Emergency situations and neonatal resuscitation.

  • Risk of Overdose: May induce CNS stimulation leading to tremors or seizures.

• Gabapentin:

  • Indications: Anxiety reduction, chronic pain management, and pre-visit calming (sedation for veterinary visits).

  • Side Effects: Sedation and ataxia.

• Neuromuscular Blockers:

  • Action: Causes motor paralysis ONLY.

  • WARNING: These agents provide ZERO analgesia and ZERO unconsciousness. Patients MUST be supported with mechanical ventilation while under the influence of these drugs.

Euthanasia and End-of-Life Care

• Primary Agent: Pentobarbital overdose.

• Mechanism of Action: Direct CNS depression leading to respiratory arrest and subsequent cardiac arrest.

• Regulatory Requirements: Controlled substance; requires meticulous documentation in controlled drug logs.

Comprehensive Drug Reference Table

High-Yield VTNE Pearls

• Acepromazine: Remember it provides sedation WITHOUT analgesia.

• Alpha2 Agonists: Frequently cause bradycardia.

• Naloxone: The specific reversal for opioids.

• Propofol: Always be prepared for apnea during induction.

• Neuromuscular Blockers: Paralyze the patient but do NOT provide anesthesia; the patient is awake and feels pain unless other drugs are used.

• Phenobarbital: Chronic use necessitates liver monitoring.

• Sevoflurane vs. Isoflurane: Sevoflurane provides a faster recovery.

• Fentanyl Patches: Potent and carry high danger if mishandled.

• Anesthesia Monitoring: Constant temperature monitoring is mandatory.

• Recovery Phase: Monitoring during recovery is just as vital to patient safety as monitoring during induction.